Publicaciones en colaboración con investigadores/as de University of Eastern Piedmont Amadeo Avogadro (12)

2024

  1. AI is a viable alternative to high throughput screening: a 318-target study

    Scientific Reports, Vol. 14, Núm. 1

  2. Correction to: AI is a viable alternative to high throughput screening: a 318-target study (Scientific Reports, (2024), 14, 1, (7526), 10.1038/s41598-024-54655-z)

    Scientific Reports

  3. Society for Immunotherapy of Cancer (SITC) recommendations on intratumoral immunotherapy clinical trials (IICT): from premalignant to metastatic disease

    Journal for ImmunoTherapy of Cancer, Vol. 12, Núm. 4

2023

  1. Correction: Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY (Leukemia, (2023), 37, 2, (339-347), 10.1038/s41375-022-01802-y)

    Leukemia

  2. Different prognostic impact of recurrent gene mutations in chronic lymphocytic leukemia depending on IGHV gene somatic hypermutation status: a study by ERIC in HARMONY

    Leukemia, Vol. 37, Núm. 2, pp. 339-347

2019

  1. Tailored approaches grounded on immunogenetic features for refined prognostication in chronic lymphocytic leukemia

    Haematologica, Vol. 104, Núm. 2, pp. 360-369

2018

  1. Richter transformation driven by Epstein–Barr virus reactivation during therapy-related immunosuppression in chronic lymphocytic leukaemia

    Journal of Pathology, Vol. 245, Núm. 1, pp. 61-73

2016

  1. Different spectra of recurrent gene mutations in subsets of chronic lymphocytic leukemia harboring stereotyped B-cell receptors

    Haematologica, Vol. 101, Núm. 8, pp. 959-967

2015

  1. Analysis of heritability and shared heritability based on genome-wide association studies for thirteen cancer types

    Journal of the National Cancer Institute, Vol. 107, Núm. 12

  2. Recurrent mutations refine prognosis in chronic lymphocytic leukemia

    Leukemia, Vol. 29, Núm. 2, pp. 329-336

2008

  1. β-catenin promotes self-renewal of skeletal-muscle satellite cells

    Journal of Cell Science, Vol. 121, Núm. 9, pp. 1373-1382

2007

  1. Control of Myf5 activation in adult skeletal myonuclei requires ERK signalling

    Cellular Signalling, Vol. 19, Núm. 8, pp. 1671-1680